Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biden’s Abortion Strategy Omits Regulatory Changes That Could Boost Mifepristone Access
Aug 29 2022
•
By
Brenda Sandburg
HHS does not propose how to overcome restrictions on abortion medication • Source: Shutterstock
More from US FDA
More from Agency Leadership